Clinical trials
Phase 1 Liver Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
| Unknown status | 14 |
| Completed | 6 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| West China Hospital | 4 |
| Beijing Immunochina Medical Science & Technology Co., Ltd. | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2 |
| Second Affiliated Hospital of Guangzhou Medical University | 2 |
| Shanghai Yunying Medical Technology | 2 |
| Zhejiang University | 2 |
| AbbVie | 1 |
| Aeon Therapeutics (Shanghai) Co., Ltd. | 1 |
| Anhui Provincial Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 38 |
| Carcinoma, Hepatocellular | 12 |
| Pancreatic Neoplasms | 7 |
| Stomach Neoplasms | 7 |
| Lung Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Esophageal Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.